Horizon Therapeutics plc
Rockville, MD, United States
Tuyet-Hang Pham is currently the Associate Director and Translational Medicine Lead at Horizon Therapeutics with over 12 years of clinical development experience in the biotech-pharmaceutical industry, 7 years of translational research at the NIH, and 4 years of clinical experience at the Johns Hopkins hospital. She has contributed to phase 1, 2, and 3 clinical trials with therapeutic area experience in immunology, inflammation, dermatology, respiratory, common and rare disorders. Previously, Tuyet-Hang Pham was the Translational Science Lead for 2 franchises, Fasenra (benralizumab) and Tezspire (tezepelumab), during her tenure at AstraZeneca.
Monday, November 13, 2023
3:15 PM – 3:25 PM PT
Disclosure information not submitted.
